{"transactions":[{"id":2650166,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":137743,"kind":"person","name":"Nayeem Sara M.","position":1,"cik":"0001709110","reported_name":"Nayeem Sara M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-30T20:08:47.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":7728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest on the first anniversary of the date of grant or, if earlier, the date of Imara's next annual meeting of stockholders following the date of grant."}],"balance_after":7728,"derivative":{"exercise_price":8.12,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":7728},"source":{"system":"sec-edgar","filing":"0001209191-21-044168","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709110/000120919121044168/doc4.xml","form_type":"4"}},{"id":3208998,"issuer":{"id":4024,"kind":"organization","name":"Enliven Therapeutics, Inc.","symbol":"ELVN"},"owners":[{"id":137743,"kind":"person","name":"Nayeem Sara M.","position":1,"cik":"0001709110","reported_name":"Nayeem Sara M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-03-16T17:23:49.000Z","date":"2020-03-16","kind":"grant","acquired":true,"shares":15457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal installments on March 16, 2021, 2022 and 2023."}],"balance_after":15457,"derivative":{"exercise_price":16,"expiration_date":"2030-03-15","underlying":"Common Stock","underlying_shares":15457},"source":{"system":"sec-edgar","filing":"0001209191-20-019342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709110/000120919120019342/doc4.xml","form_type":"4"}},{"id":4107738,"issuer":{"id":69982,"kind":"organization","name":"Mersana Therapeutics, Inc.","symbol":"MRSN"},"owners":[{"id":137743,"kind":"person","name":"Nayeem Sara M.","position":1,"cik":"0001709110","reported_name":"Nayeem Sara M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T16:31:30.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":3560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal quarterly installments on the last day of each calendar quarter of 2018."}],"balance_after":3560,"derivative":{"exercise_price":17.39,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":3560},"source":{"system":"sec-edgar","filing":"0001209191-18-001959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709110/000120919118001959/doc4.xml","form_type":"4"}}]}